Forbes

Trending

Rundown

Trump's Economic Approval Rating Hits New Low Jobless Claims Rose By Most Since 2020 Last Week 2025’s Biggest AI Deals, Ranked: Disney Invests $1 Billion In OpenAI

The Rundown is generated by AI. Learn More.

Daily Cover Story

How The King Of Beef Jerky Became A Billionaire

Jack Link’s $4 billion family-owned business is the largest manufacturer of jerky in the world, selling 800 million packages of meat snacks and other products a year. But the company namesake and his son are still hungry for more.

ByChloe Sorvino,

Forbes Staff

Billionaires

MacKenzie Scott’s Latest Gifts Make Her America’s Third Most Generous Philanthropist

ByPhoebe Liu,

Forbes Staff

Economy

Year-End Bonuses Are Shrinking And 2026 Raises Will Be Modest. But Not For Everyone.

ByMaria Gracia Santillana Linares,

Forbes Staff

Billionaires

Larry Ellison—Losing $31 Billion—Stumbles To No. 3 Richest As Oracle Shares Plummet

ByTy Roush,

Forbes Staff

SportsMoney

The NHL’s Most Valuable Teams 2025

ByJustin Teitelbaum,

Forbes Staff

andBrett Knight,

Forbes Staff

30 Under 30

“One-Stop” Electronics Giant Yageo Eyes More Overseas Investment After Japan Stake

ByRussell Flannery,

Senior Contributor

Indonesian Billionaires Cash In On Gold Surge

ByArdian Wibisono,

Forbes Staff

Savvy Bets Return Media Mogul To Ranks Of Indonesia’s Richest

ByGloria Haraito,

Forbes Staff

Tobacco Heir Putera Sampoerna Exits Palm Oil, Eyes New Frontiers

ByYessar Rosendar,

Forbes Staff

Billionaires

Asia

Volatile Oil Prices Spur Indonesian Energy Tycoon To Get Gung-Ho On Gas

ByYessar Rosendar,

Forbes Staff

Asia

Indonesia’s 50 Richest 2025: Wealth Crosses $300 Billion Amid Stock Market Frenzy; Data Center Billionaires Climb Into The Top 10

ByJane Ho,

Forbes Staff

andPhisanu Phromchanya,

Contributor

Innovation

Medline’s Founding Family Has $6 Billion-Plus Stake In Its Upcoming Blockbuster IPO

ByAmy Feldman,

Forbes Staff

andAndrea Murphy,

Forbes Staff

Billionaires

How Donald Trump Jr’s Fortune Jumped Six-Fold In A Year

ByKyle Khan-Mullins,

Forbes Staff

Money & Markets

Last Updated: 12/11/2025 04:00 PM EST

Taxes

Why 2026 Could Be A Good Year For Planned Charitable Giving

ByKelly Phillips Erb,

Forbes Staff

Personal Finance

5 Takeaways For Student Loans As Millions Forced To Switch Repayment Plans

ByAdam S. Minsky,

Senior Contributor

Investing

Powell Signals Possible Pause In Interest Rate Cuts For Now

BySimon Moore,

Senior Contributor

Money

Netflix’s Queen Of Screens

ByManeet Ahuja,

Forbes Staff

Forbes Vetted

I’m Tracking 163 Cyber Monday Deals You Can Still Shop Today

ByJordan Thomas,

Forbes Staff

Forbes Vetted

Lululemon’s Cyber Monday Sale May Be Over But We Still Found 38 Live Deals

ByMolly Calhoun,

Forbes Staff

andSteven John,

Forbes Staff

Forbes Vetted

Help Reverse Hair Loss With The IRestore Hair Growth System

BySponsor: iRestore,

Forbes Staff

andBrooke Bajgrowicz,

Forbes Staff

Forbes Vetted

57 Best White Elephant Gift Ideas To Cause (Friendly) Chaos

ByFran Sales,

Forbes Staff

Forbes Vetted

Omnilux Sale: Save $89 On LED Masks With Our Exclusive Code

ByMaya Gandara,

Forbes Staff

andKatherine Louie,

Forbes Staff

Education

Money

Forbes’ Top 25 Public Colleges

ByFiona Riley,

Contributor

Education

Two Prominent, Private Oregon Universities Plan To Merge

ByMichael T. Nietzel,

Senior Contributor

Education

The Big Poach: Canada To Spend $1.2 Billion To Recruit Top Researchers

ByMichael T. Nietzel,

Senior Contributor

Transportation

Waymos Were Passing Stopped School Buses. Let’s Rethink School Buses.

ByBrad Templeton,

Senior Contributor

Lifestyle

Vices

White House Says President Trump Has Made ‘No Final Decisions’ Around Marijuana Rescheduling

A report stating that the administration is close to reclassifying cannabis as a Schedule III drug—on par with mild painkillers—has the $32 billion industry hotly anticipating reform.

ByWill Yakowicz,

Forbes Staff